Similar articles

• Chromosome mechanisms giving rise to the TMPRSS2-ERG fusion oncogene in prostate cancer and HGPIN lesions.

  Teixeira MR. Teixeira MR. Am J Surg Pathol. 2008 Apr;32(4):642-4; author reply 644. doi: 10.1097/PAS.0b013e31815b6056. Am J Surg Pathol. 2008. PMID: 18317354 No abstract available.
• Genome-wide linkage analysis of TMPRSS2-ERG fusion in familial prostate cancer.

  Hofer MD, Kuefer R, Maier C, Herkommer K, Perner S, Demichelis F, Paiss T, Vogel W, Rubin MA, Hoegel J. Hofer MD, et al. Cancer Res. 2009 Jan 15;69(2):640-6. doi: 10.1158/0008-5472.CAN-08-2008. Cancer Res. 2009. PMID: 19147579
• TMPRSS2-ERG fusion prostate cancer: an early molecular event associated with invasion.

  Perner S, Mosquera JM, Demichelis F, Hofer MD, Paris PL, Simko J, Collins C, Bismar TA, Chinnaiyan AM, De Marzo AM, Rubin MA. Perner S, et al. Am J Surg Pathol. 2007 Jun;31(6):882-8. doi: 10.1097/01.pas.0000213424.38503.aa. Am J Surg Pathol. 2007. PMID: 17527075
• Complex rearrangement of chromosomes 19, 21, and 22 in Ewing sarcoma involving a novel reciprocal inversion-insertion mechanism of EWS-ERG fusion gene formation: a case analysis and literature review.

  Maire G, Brown CW, Bayani J, Pereira C, Gravel DH, Bell JC, Zielenska M, Squire JA. Maire G, et al. Cancer Genet Cytogenet. 2008 Mar;181(2):81-92. doi: 10.1016/j.cancergencyto.2007.11.002. Cancer Genet Cytogenet. 2008. PMID: 18295659 Review.
• The discovery of common recurrent transmembrane protease serine 2 (TMPRSS2)-erythroblastosis virus E26 transforming sequence (ETS) gene fusions in prostate cancer: significance and clinical implications.

  Shah RB, Chinnaiyan AM. Shah RB, et al. Adv Anat Pathol. 2009 May;16(3):145-53. doi: 10.1097/PAP.0b013e3181a12da7. Adv Anat Pathol. 2009. PMID: 19395877 Review.